glp-1 gerd For patients taking receptor agonists (GLP-1 RAs), the use of proton pump inhibitors (PPIs) is associated with an increased risk for gastrointestinal (GI) adverse effects, according to research presented at the GLP-1 Medications May Increased the
Description
10.1038/s41574-018-0048-7 Nat

"*" indicates required fields

The role of the vagal nervous system in mediating the effects of GLP-1 on gastric accommodation was studied by the same group [50]

In Alzheimers Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial

[DOI] [PubMed] [Google Scholar] 80.Anderberg R.H., Richard J.E., Hansson C., Nissbrandt H., Bergquist F., Skibicka K.P
